07.02.26 -- Why Improving Drug Delivery Remains A Major Opportunity In Oncology

Evaluate how purpose-driven digital technology, predictive maintenance, and modular design can successfully streamline your production timelines and improve operational agility.

Explore the scientific, medical, and operational factors crucial for integrating oncology biomarkers into clinical trials, from patient stratification to commercial scale.

Gain practical insights into the manufacturing realities shaping in vivo CAR-T development and learn how leading teams are addressing the challenges of scaling both LNP and viral vector platforms.

Low-shear, closed-system media exchange in iPSC differentiation is vital for scalability. This study compares automated centrifugation to gravity sedimentation, showing equivalent or superior differentiation outcomes.

Compare four common applications of cryopreservation and the science behind selecting the appropriate materials to build single-use solutions that enable cryogenic storage for cell and gene applications.

Smarter viral vector manufacturing starts with early alignment, realistic scaling, and collaboration. Strategy and transparency reduce risk, control costs, and keep timelines on patients.

Transposons are an efficient and cost-effective method for gene transfer in cell engineering and therapies. Their delivery can be optimized to improve cell expansion and functionality.

Continuous bioprocessing is revolutionizing biotherapeutic manufacturing. Discover cutting-edge innovations in monoclonal antibody production that enable scalable solutions for next-gen therapies.

Personalized cancer vaccines need fast, flexible manufacturing. Cell‑free synthetic DNA enables rapid, small‑batch mRNA production, supporting individualized therapies beyond plasmid‑based limits.